Long-term follow-up of BVS from a prospective multicenter registry: Impact of a dedicated implantation technique on clinical outcomes-Reference-Cited by-同舟云学术

Long-term follow-up of BVS from a prospective multicenter registry: Impact of a dedicated implantation technique on clinical outcomes

Published:2018-11 Issue: Volume:270 Page:113-117
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Regazzoli Damiano^ORCID,Latib Azeem^ORCID,Ezhumalai Babu^ORCID,Tanaka Akihito^ORCID,Leone Pier Pasquale,Khan Sara,Kumar Vijay,Rastogi Vishal,Ancona Marco Bruno,Mangieri Antonio^ORCID,Giannini Francesco,Mitomo Satoru,Seth Ashok,Colombo Antonio

Funder

Abbott Vascular

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Everolimus-eluting bioresorbable scaffolds for coronary artery disease;Ellis;N. Engl. J. Med.,2015

2. Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization?;Onuma;Circulation,2011

3. Is multislice computed tomography a feasible option for follow-up of complex coronary lesions treated with bioresorbable scaffolds?;Regazzoli;JACC Cardiovasc. Interv.,2016

4. Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial;Serruys;Lancet,2016

5. Bioresorbable scaffolds versus metallic stents in routine PCI;Wykrzykowska;N. Engl. J. Med.,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of post-implantation time on bioresorbable vascular scaffold outcomes for type C versus non-type C coronary lesions: A longer-term study;Journal of the Formosan Medical Association;2023-10

2. Lesion impacts on long-term outcomes in patients implanted with bioresorbable vascular scaffold;Journal of the Formosan Medical Association;2021-11

3. Five Years Outcomes and Predictors of Events in a Single-Center Cohort of Patients Treated with Bioresorbable Coronary Vascular Scaffolds;Journal of Clinical Medicine;2020-03-20

4. Hybrid Coronary Percutaneous Treatment with Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-Years Results from the GABI-R Registry;Journal of Clinical Medicine;2019-05-30

5. Should we stop using bioresorbable scaffolds in coronary revascularisation?;EuroIntervention;2019-05